Pharmacogenomics of hepatitis C infections: personalizing therapy.
about
Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis.A quick guide to genomics and bioinformatics training for clinical and public audiences.Genetic predictors of the response to the treatment of hepatitis C virus infection.Genomic medicine: a decade of successes, challenges, and opportunities.
P2860
Pharmacogenomics of hepatitis C infections: personalizing therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pharmacogenomics of hepatitis C infections: personalizing therapy.
@ast
Pharmacogenomics of hepatitis C infections: personalizing therapy.
@en
type
label
Pharmacogenomics of hepatitis C infections: personalizing therapy.
@ast
Pharmacogenomics of hepatitis C infections: personalizing therapy.
@en
prefLabel
Pharmacogenomics of hepatitis C infections: personalizing therapy.
@ast
Pharmacogenomics of hepatitis C infections: personalizing therapy.
@en
P2093
P2860
P356
P1433
P1476
Pharmacogenomics of hepatitis C infections: personalizing therapy.
@en
P2093
David R Booth
Golo Ahlenstiel
Jacob George
P2860
P2888
P356
10.1186/GM400
P577
2012-12-26T00:00:00Z
P5875
P6179
1002995184